Cosmetic product claims are one of the most common sources of regulatory violations in the United States. While cosmetic labels and marketing materials are powerful tools for attracting consumers, they are also closely regulated by the US FDA. Claims that overstep legal boundaries can cause a cosmetic to be misbranded, reclassified as a drug, or both.
With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), claim compliance has become even more important. The US FDA now has expanded authority to access records, review substantiation, and mandate recalls when products present safety or regulatory concerns.
XPRO America is a professional US FDA Consultancy supporting cosmetic brands with claim review, risk classification, and MoCRA-aligned compliance strategies.
What Are Cosmetic Product Claims
Cosmetic product claims are statements that describe what a cosmetic product does or how it affects appearance.
Claims may appear on:
- Product labels
- Packaging
- Websites
- Social media
- Advertising materials
- E-commerce listings
All claims are subject to US FDA oversight.
How US FDA Defines a Cosmetic Claim
A cosmetic claim describes effects related to:
- Cleansing
- Beautifying
- Promoting attractiveness
- Altering appearance
Examples of acceptable cosmetic claims:
- “Moisturizes dry skin”
- “Adds shine to hair”
- “Smooths the look of wrinkles”
- “Enhances skin radiance”
These claims focus on appearance, not treatment or cure.
Cosmetic Claims vs Drug Claims
The most critical compliance distinction is between cosmetic claims and drug claims.
Cosmetic Claims
- Affect appearance only
- Do not treat disease
- Do not alter body structure or function
Drug Claims
- Treat or prevent disease
- Affect structure or function of the body
Examples of drug claims:
- “Treats acne”
- “Heals eczema”
- “Kills bacteria”
- “Stimulates collagen production”
If a cosmetic makes drug claims, it becomes subject to drug regulations, including premarket approval.
Why Claim Compliance Matters
Improper claims may cause:
- Product reclassification as a drug
- Misbranding findings
- Warning letters
- Import refusal
- Mandatory recalls under MoCRA
Claim violations are one of the fastest ways to trigger enforcement action.
Label Claims and Marketing Claims Are Treated the Same
US FDA does not distinguish between:
- Label claims
- Website claims
- Social media claims
If the company controls the content, the claim is regulated.
Deleting a claim after enforcement action does not eliminate liability.
Substantiation of Cosmetic Claims
All cosmetic claims must be truthful and not misleading.
Companies must maintain evidence supporting:
- Performance claims
- Consumer perception claims
- Ingredient-related claims
Examples of acceptable substantiation:
- Test results
- Consumer use studies
- Technical data
- Literature references
Unsupported claims may be considered misleading.
High-Risk Claim Categories
Certain claim types attract increased scrutiny:
- Anti-aging
- Acne-related
- Antibacterial / antimicrobial
- SPF / sun protection
- Hair growth
- Skin lightening / whitening
These claims often cross into drug territory if not carefully worded.
XPRO America reviews high-risk claims before market release.
“Natural,” “Organic,” and “Clean” Claims
The US FDA does not formally define these terms for cosmetics.
However, claims must still be truthful and not misleading.
Common risks:
- “100% organic” without documentation
- “Chemical-free” claims
- “Toxin-free” claims
Such statements require strong substantiation.
Ingredient-Based Claims
Claims such as:
- “Contains vitamin C”
- “With hyaluronic acid”
Must be accurate and reflect actual formulation content.
Overstating ingredient benefits may create misleading impressions.
Claims and MoCRA Safety Substantiation
Under MoCRA, companies must maintain adequate safety substantiation.
If a claim implies a certain level of activity or exposure, safety substantiation must support that use scenario.
Claims and safety documentation must align.
Claims and Misbranding
A cosmetic is considered misbranded if:
- Claims are false or misleading
- Claims imply drug action
- Claims cannot be substantiated
Misbranded cosmetics are illegal to sell in the United States.
Import Implications
Imported cosmetics with problematic claims may be:
- Detained at port
- Refused entry
- Placed on import alert
Pre-export claim review is strongly recommended.
Common Claim Mistakes
- Using medical terminology
- Copying competitor claims
- Making absolute claims (“guaranteed results”)
- Using testimonials that imply treatment
- No substantiation files
These errors significantly increase enforcement risk.
Best Practices for Cosmetic Claim Compliance
- Perform claim classification review
- Identify cosmetic vs drug risk
- Maintain substantiation files
- Align claims with safety documentation
- Review claims across all platforms
- Work with an experienced US FDA Consultancy
How XPRO America Supports Claim Compliance
XPRO America operates as a trusted US FDA Consultancy providing:
- Claim risk classification
- Cosmetic vs drug assessment
- Substantiation review
- Label and marketing audits
- MoCRA compliance alignment
- Regulatory strategy consulting
For professional assistance, contact support@xproamerica.com.
Compliance Perspective
Cosmetic product claims determine how the US FDA legally views your product. Even a well-formulated cosmetic can become illegal if claims cross regulatory boundaries. Under US FDA authority and MoCRA enforcement, careful claim management is essential.
With expert guidance from XPRO America, cosmetic brands can create compelling, compliant claims that support marketing goals while maintaining full US FDA compliance.
Leave a Reply